Open Access

Anticoagulants in cardiovascular disease – from basics to translation

Event: Frontiers in CardioVascular Biology 2016
Topic: Miscellaneous
Session type: Symposium
Date: 8 July 2016
Time: 12:45 - 14:45

Session

6 presentations in this session

Thrombosis revisited: the role of platelets and thrombin in venous and arterial thrombosis.

Speaker: Professor A. Siegbahn (Uppsala, SE)
Thumbnail

Anticoagulation therapy in 2016 and beyond: from theory to practice.

Speaker: Doctor J. Weitz (Hamilton, CA)
Thumbnail

NOACs for treatment of venous thromboembolism: where are we, and where are we going?

Speaker: Professor W. Ageno (Varese, IT)
Thumbnail

NOACs in atrial fibrillation and coronary heart disease: where are we and where are we going?

Speaker: Professor R. De Caterina (Pisa, IT)
Thumbnail

Monitoring NOACs: heresy or care refinement?

Speaker: Doctor M. Levi (Amsterdam, NL)
Thumbnail

Reversal of non-vitamin K antagonist oral anticoagulants: true need or perception in search of solutions.

Speaker: Doctor J. Van Ryn (Biberach, DE)
Thumbnail

6 speakers from this session

Professor Agneta Siegbahn

Uppsala University, Uppsala (Sweden)
1 presentation
0 follower

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)
20 presentations
0 follower

Professor Walter Ageno

University of Insubria, Varese (Italy)
3 presentations
0 follower

Professor Raffaele De Caterina

University Hospital of Pisa, Pisa (Italy)
25 presentations
1 follower

Doctor Marcel M Levi

, Amsterdam (Netherlands (The))
1 presentation
0 follower

Doctor Joanne Van Ryn

Boehringer Ingelheim Pharma GmbH & Co KG, Biberach (Germany)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk